NOT-AR-23-012: Notice of NIAMS' Participation in RFA-TR-22-030, "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)"

Notice of NIAMS' Participation in RFA-TR-22-030, "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)"

Notice Number:

NOT-AR-23-012

Key Dates

Release Date:

January 23, 2023

Related Announcements

RFA-TR-22-030 - Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate in RFA-TR-22-030 "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trials Not Allowed)" effective for the March 15, 2023 due date and subsequent due dates. The following changes and updates have been made to RFA-TR-22-030 (shown in bold italics) to reflect NIAMS' participation in this FOA.

Part 1. Overview Information

Components of Participating Organizations

National Center for Advancing Translational Sciences (NCATS)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.350, 93.242, 93.853, 93.846

Scientific/Research Contact(s)

Karlie Sharma, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-451-4965
Email: [email protected]

Enrique Michelotti, PhD
National Institute of Mental Health (NIMH)
Telephone: 301-443-5415
Email: [email protected]

Severn B. Churn, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
301-503-2889
[email protected]

Emily Carifi, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-596-0665
Email: [email protected]v

Financial/Grants Management Contact(s)

Steve Elsberg
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-0961
Email: [email protected]

Heather Weiss
National Institute of Mental Health (NIMH)
Telephone: 301-443-4415
Email: [email protected]

Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)
Email: [email protected]

Sahar Rais-Danai
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032
Email: [email protected]

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Emily Carifi, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-596-0665
Email: [email protected]